Literature DB >> 23196359

Phomopsis bougainvilleicola prepatellar bursitis in a renal transplant recipient.

Paloma F Cariello1, Brian L Wickes, Deanna A Sutton, Lisa A Castlebury, Stuart M Levitz, Robert W Finberg, Elizabeth H Thompson, Jennifer S Daly.   

Abstract

Prepatellar bursitis is typically a monomicrobial bacterial infection. A fungal cause is rarely identified. We describe a 61-year-old man who had received a renal transplant 21 months prior to presentation whose synovial fluid and surgical specimens grew Phomopsis bougainvilleicola, a pycnidial coelomycete.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23196359      PMCID： PMC3553907          DOI： 10.1128/JCM.02674-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.

Authors:  Stéphane Guindon; Jean-François Dufayard; Vincent Lefort; Maria Anisimova; Wim Hordijk; Olivier Gascuel
Journal:  Syst Biol       Date:  2010-03-29       Impact factor: 15.683

2.  Invasive fungal disease after remote inoculation in transplant recipients.

Authors:  Francisco M Marty; Eva M Petschnigg; Sarah P Hammond; John E Ready; Vincent T Ho; Robert J Soiffer; Colm Magee; Danny A Milner; Joseph H Antin; Lindsey R Baden
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

3.  Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.

Authors:  D Capone; G Tarantino; A Gentile; M Sabbatini; G Polichetti; M Santangelo; R Nappi; A Ciotola; V D'Alessandro; A Renda; V Basile; S Federico
Journal:  J Clin Pharm Ther       Date:  2010-02       Impact factor: 2.512

4.  Sequence-based identification of filamentous basidiomycetous fungi from clinical specimens: a cautionary note.

Authors:  Anna M Romanelli; Deanna A Sutton; Elizabeth H Thompson; Michael G Rinaldi; Brian L Wickes
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

5.  Coelomycetous fungi in human disease. A review: Clinical entities, pathogenesis, identification and therapy.

Authors:  D A Sutton
Journal:  Rev Iberoam Micol       Date:  1999-12       Impact factor: 1.044

6.  Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

Authors:  Robert A Wermers; Kay Cooper; Raymund R Razonable; Paul J Deziel; Gary M Whitford; Walter K Kremers; Thomas P Moyer
Journal:  Clin Infect Dis       Date:  2011-01-16       Impact factor: 9.079

Review 7.  Management of drug and food interactions with azole antifungal agents in transplant recipients.

Authors:  Elizabeth Dodds-Ashley
Journal:  Pharmacotherapy       Date:  2010-08       Impact factor: 4.705

8.  Fungal scleral keratitis caused by Phomopsis phoenicicola.

Authors:  Devarshi U Gajjar; Anuradha K Pal; Trilok J Parmar; Anshul I Arora; Darshini A Ganatra; Forum B Kayastha; Bharat K Ghodadra; Abhay R Vasavada
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

Review 9.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

10.  Human phaeohyphomycotic osteomyelitis caused by the coelomycete Phomopsis saccardo 1905: criteria for identification, case history, and therapy.

Authors:  D A Sutton; W D Timm; G Morgan-Jones; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948
View more
  2 in total

Review 1.  Fungal Olecranon Bursitis in an Immunocompetent Patient by Knoxdaviesia dimorphospora sp. nov.: Case Report and Review.

Authors:  Marcela Guevara-Suarez; Marta Llaurado; Isabel Pujol; Emilio Mayayo; Adela Martin-Vicente; Josepa Gené
Journal:  Mycopathologia       Date:  2017-10-09       Impact factor: 2.574

2.  Soft Tissue Infection with Diaporthe phaseolorum in Heart Transplant Recipient with End-Stage Renal Failure.

Authors:  Julia C Howard; Kevin Chen; Anja Werno; Sarah Metcalf
Journal:  Emerg Infect Dis       Date:  2019-09-17       Impact factor: 6.883
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.